0000721371-22-000181.txt : 20221219 0000721371-22-000181.hdr.sgml : 20221219 20221219065803 ACCESSION NUMBER: 0000721371-22-000181 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20221216 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221219 DATE AS OF CHANGE: 20221219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CARDINAL HEALTH INC CENTRAL INDEX KEY: 0000721371 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 310958666 STATE OF INCORPORATION: OH FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11373 FILM NUMBER: 221469584 BUSINESS ADDRESS: STREET 1: 7000 CARDINAL PLACE CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147573033 MAIL ADDRESS: STREET 1: 7000 CARDINAL PLACE CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: CARDINAL DISTRIBUTION INC DATE OF NAME CHANGE: 19920703 8-K 1 cah-20221216.htm 8-K cah-20221216
0000721371false00007213712022-12-162022-12-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 16, 2022
 
Cardinal Health, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Ohio 1-11373 31-0958666
(State or Other Jurisdiction
of Incorporation)
 (Commission
File Number)
 (IRS Employer
Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017
(Address of Principal Executive Offices) (Zip Code)
(614) 757-5000
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common shares (without par value)CAHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨





Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On December 16, 2022, the Board of Directors of Cardinal Health, Inc. (the “Company”) elected Aaron E. Alt, 51, as Chief Financial Officer (“CFO”) of the Company, effective February 10, 2023. Mr. Alt will succeed Patricia M. English, who will continue to serve as interim CFO until February 10, 2023.

Mr. Alt has served as Executive Vice President and Chief Financial Officer of Sysco Corporation, a foodservice distribution company, since December 2020. Prior to that, Mr. Alt served as Senior Vice President and Chief Financial Officer of Sally Beauty Holdings, Inc., an international specialty retailer and distributor of professional beauty supplies, and President of Sally Beauty Supply from October 2018 to November 2020. Prior to that, Mr. Alt was Sally Beauty Holdings' Senior Vice President, Chief Financial Officer, and Chief Administrative Officer from May 2018 to October 2018. Prior to joining Sally Beauty Holdings, Mr. Alt held various senior operational and financial roles at Target Corporation, a general merchandise retailer, including Senior Vice President, Operations from March 2017 to May 2018. Prior to joining Target, Mr. Alt held several senior level positions with Sara Lee Corporation and was a partner at the law firm of Kirkland & Ellis in London.

Pursuant to the terms of Mr. Alt's offer letter with the Company, he will receive an annual base salary at the rate of $825,000, a target annual bonus at 110% of his salary, and target long-term incentive awards of $3,500,000. To address compensation forfeited at his former employer, Mr. Alt will receive (i) a cash sign-on bonus of $1,000,000, (ii) an initial grant of performance share units with a grant value of $2,500,000 that are eligible to vest based on performance over a three-year performance period, and (iii) an initial grant of time-vesting restricted shares units with a grant value of $1,000,000 that vest ratably over three years. He will also receive a $250,000 lump sum payment for relocation in lieu of eligibility for the Company's executive relocation program. A copy of the offer letter is attached hereto as Exhibit 10.1 and is incorporated herein by reference, and the description above is qualified in its entirety by reference thereto. For more information regarding the Company’s annual bonus and long-term incentive award programs, see the Company’s Definitive Proxy Statement for the 2022 Annual Meeting of Shareholders filed with the Securities and Exchange Commission on September 28, 2022.

The Company also entered into its standard form of executive Confidentiality and Business Protection Agreement with Mr. Alt, which is attached hereto as Exhibit 10.2 and is incorporated herein by reference.

Item 7.01. Regulation FD

The Company issued a news release on December 19, 2022 announcing the appointment of Mr. Alt as CFO, which is being furnished as Exhibit 99.1 to this Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.
10.1
10.2
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  Cardinal Health, Inc.
(Registrant)
Date: December 19, 2022  By: /s/ Jessica L. Mayer
   Name: Jessica L. Mayer
   
Title: Chief Legal and Compliance Officer

3
EX-10.1 2 altofferletter.htm EX-10.1 Document
Exhibit 10.1
image_0.jpg
Ola M. Snow
Chief Human Resources Officer
Cardinal Health
7000 Cardinal Place
Dublin, Ohio 43017
614.XXX.XXXX tel
614.XXX.XXXX fax



cardinalhealth.com


December 12, 2022

Aaron Alt


Dear Aaron,

It is with great pleasure that I confirm in writing our offer of employment to you. All of us who have met with you enthusiastically believe you represent an exceptional fit with Cardinal Health, Inc. ("Cardinal Health") and will be a superb addition to the executive management team. As we have discussed, the terms of this offer are subject to approval by the Human Resources and Compensation Committee of our Board of Directors (“Compensation Committee”). The major provisions of your offer are:

Position: Your initial position will be Executive Vice President, Finance, based in Dublin, Ohio and reporting to Jason Hollar, Chief Executive Officer, Cardinal Health. You will become Chief Financial Officer (CFO) effective on February 10, 2023.

Start Date: Your start date will be January 16, 2023.

Base Salary: Your annual salary is $825,000; it is payable bi-weekly, every other Friday, one week behind the most current workweek you’ve completed (in arrears). You will be annually eligible for adjustments to your base salary rate, subject to both merit funding guidelines and your performance.

Management Incentive Plan: You will be annually eligible to participate in our short-term cash incentive plan, which we call the Management Incentive Plan ("MIP"). Your target incentive for the fiscal year ending June 30, 2023 will be 110% of your annual base salary, prorated to reflect the number of days you are employed in this position during the fiscal year. MIP funding is determined by the Compensation Committee based upon the achievement of both financial and non-financial objectives.

Long-Term Incentive Awards: You will also be eligible to receive annual grants of long-term incentive (“LTI”) awards, with a target award value of $3,500,000. Currently, LTI grants are awarded in August of each year; the first LTI grant for which you will be eligible is scheduled to occur in August 2023 for the fiscal year ending June 30, 2024. The grant is expected to be awarded in a mix of 40% restricted share units ("RSUs") and 60% performance share units (“PSUs”). Your RSUs and PSUs scheduled to be granted in August 2023 may be subject to deferred payment if you so elect before your start date. Annual LTI grant participation, award amounts, forms of awards, and award terms are reviewed on an annual basis and are subject to change at any time at the discretion of the Compensation Committee. Standard terms and conditions apply.

One-time Payments and Grants: To address forfeited compensation and incent and assist you in transitioning to this new role, we will provide you with:

A gross cash sign-on bonus of $1,000,000, to be paid within 30 days from your start date. It is understood that if prior to completing one year of service, you are terminated for cause or if you voluntarily terminate employment with Cardinal Health, you would be responsible for reimbursing to Cardinal Health 100% of this sign-on bonus. If such a termination event occurs after one year of service, but before the completion of two years, you would be responsible for reimbursing to Cardinal Health 50% of this sign-on bonus. By signing this offer letter, you agree that Cardinal Health may withhold any amounts due from your final paycheck, as they relate to the above.



Mr. Aaron Alt
Page 2 of 3


You will be awarded an LTI grant with an expected value of $3,500,000 as of the grant date, with $2,500,000 delivered in PSUs and $1,000,000 delivered in RSUs subject to approval by the Compensation Committee. Per our standard practice, the grant will be made on the 15th calendar day of the month following your start date. The awards will be valued in accordance with Cardinal Health’s standard valuation practices. Standard terms and conditions apply. These RSUs and PSUs may be subject to deferred payment if you so elect before your start date.

Relocation: In lieu of eligibility for our Executive Homeowner Relocation Program, we will provide you with a $250,000 lump sum payment for your intended relocation within 12 months of your start date. It is understood that if you are terminated for cause or you voluntarily terminate employment with Cardinal Health before completing one year of service, you would be responsible for reimbursing to Cardinal Health 100% of this payment. If such a termination event occurs after one year of service, but before the completion of two years, you would be responsible for reimbursing to Cardinal Health 50% of this payment. By signing this offer letter, you agree that Cardinal Health may withhold any amounts due from your final paycheck, as they relate to the above.

Well-Being Opportunities: Cardinal Health is pleased to offer a comprehensive, competitive program. On your first day of employment, you are eligible to participate in the:

Health, Life and Disability Plans – You will receive more information on these benefits in advance of your start date and during your new hire orientation session.

401(k) Savings Plan – You are eligible to participate in the Cardinal Health 401(k) Savings Plan on the first day of your employment. You may contribute up to 50% of your pre-tax earnings to the Plan (subject to IRS maximum limits). Currently, if you contribute 5% or more you will receive the maximum company matching contribution of 4%. Cardinal Health also matches contributions from below 5% at various levels, and we can provide additional details upon request. These matching dollars are immediately 100% vested. In addition to the company match, Cardinal Health may make discretionary company contributions to your 401(k) account. These discretionary company contributions are 100% vested after three years of service. Enrollment information will be sent to you by Principal, our financial benefits service provider.

Deferred Compensation Plan – You are eligible to participate in the Cardinal Health Deferred Compensation Plan (“DCP”). This plan enables you to defer compensation to save and invest beyond 401(k) plan limits set by the IRS. You may defer up to 50% of your base salary in 2023. Cardinal Health provides up to a 4% match on eligible compensation earned between $330,000 and $430,000 and may also make a discretionary company contribution to your DCP account. Matching contributions are immediately 100% vested and will be made on a per pay basis. Discretionary company contributions are 100% vested after 3 years. Enrollment information will be sent to you via e-mail by our Benefits department April 1. DCP annual enrollment occurs near the end of the calendar year. During the annual enrollment period you may make changes to any future DCP elections.

Paid Time Off – Cardinal Health believes that taking time off from work is essential, both personally and professionally. We do not limit the number of sick and vacation days you may take during the year. However, you are expected to balance your work and time off appropriately with respect to business and staffing needs.

Screening: Consistent with our policies for all Cardinal Health personnel and the special consideration of our industry, this offer is contingent upon both the taking of a company paid drug screening test, the results of which must be negative, as well as an acceptable background check. These items must be completed prior to your start date.

Terms: Employment with Cardinal Health is not for any definite period of time and is terminable, with or without notice, at the will of either you or Cardinal Health at any time, for any reason. There is no contract, express or implied, of employment. However, you agree to be bound by the terms of a Confidentiality and Business Protection Agreement. That agreement must be signed and delivered to Cardinal Health on or before your start date.

Ethics: As a company founded on a core set of values, we will ask you to review the enclosed Standards of Business Conduct and sign a certificate of compliance.

If you have any questions, please feel free to call me at 614.XXX.XXXX.



Mr. Aaron Alt
Page 3 of 3


I'm looking forward to working together and excited about what we will accomplish!

Sincerely,


/s/ Ola M. Snow


Ola M. Snow
Chief Human Resources Officer


I accept the above offer of employment:



/s/ Aaron E. Alt______________________________              12.12.22_________________________
Signature                                                                                   Date



cc: Jason Hollar





EX-10.2 3 altcbpagreement.htm EX-10.2 Document
Exhibit 10.2
Confidentiality and Business Protection Agreement

This Confidentiality and Business Protection Agreement (“Agreement”) is hereby entered into by and between Aaron E. Alt (“Executive”) and Cardinal Health, Inc., an Ohio Corporation (the “Company”), effective as of Executive’s start date at the Company.

It is hereby agreed as follows:

1.Consideration and Acknowledgements. The parties acknowledge that the provisions and covenants contained in this Agreement are ancillary and material to, and in consideration of, the offer letter dated December 12, 2022 and that the limitations contained herein are reasonable in geographic and temporal scope and do not impose a greater restriction or restraint than is necessary to protect the goodwill and other legitimate business interests of the Company. The parties also acknowledge and agree that the provisions of this Agreement do not adversely affect Executive's ability to earn a living in any capacity that does not violate the covenants contained herein. The parties further acknowledge and agree that the provisions of Section 9(a) below are accurate and necessary because (i) this Agreement is entered into in the State of Ohio, (ii) Ohio has a substantial relationship to the parties and to this transaction, (iii) Ohio is the headquarters state of the Company, which has operations worldwide and has a compelling interest in having its employees treated uniformly, (iv) the use of Ohio law provides certainty to the parties in any covenant litigation in the United States, and (v) enforcement of the provisions of this Agreement would not violate any fundamental public policy of Ohio or any other jurisdiction.
2.Confidential Information. Executive shall hold in a fiduciary capacity for the benefit of the Company and all of its subsidiaries, partnerships, joint ventures, limited liability companies and other affiliates (collectively, the "Cardinal Group"), all secret or confidential information, knowledge or data relating to the Cardinal Group and its businesses (including, without limitation, any proprietary and not publicly available information concerning any processes, methods, trade secrets, research, secret data, costs, names of users or purchasers of their respective products or services, business methods, operating procedures or programs or methods of promotion and sale) that Executive has obtained or obtains during Executive's employment by the Cardinal Group and that is not public knowledge (other than as a result of Executive's violation of this Agreement) ("Confidential Information"). For the purposes of this Agreement, information shall not be deemed to be publicly available merely because it is embraced by general disclosures or because individual features or combinations thereof are publicly available. Executive shall not communicate, divulge or disseminate Confidential Information at any time during or after Executive's employment with the Cardinal Group, except with prior written consent of the applicable Cardinal Group company, or as otherwise required by law or legal process. All records, files, memoranda, reports, customer lists, drawings, plans, documents and the like that Executive uses, prepares or comes into contact with during the course of Executive's employment shall remain the sole property of the Company or the Cardinal Group company, as applicable, and shall be turned over to the applicable Cardinal Group company upon termination of Executive's employment.
Notwithstanding any other provision of this Agreement, however, under the federal Defend Trade Secrets Act of 2016, Executive shall not be held criminally or civilly liable under any federal or state trade secret law or this or any other agreement for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made to Executive’s attorney in relation to a lawsuit for retaliation against Executive for reporting a suspected violation of law; or (c) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.



Nothing in this Agreement shall (a) prevent Executive from testifying truthfully as required by law (b) prohibit or prevent Executive from filing a charge with or participating, testifying, or assisting in any investigation, hearing, whistleblower proceeding or other proceeding before any federal, state, or local government agency (e.g. EEOC, NLRB, SEC, etc.), or (c) prevent Executive from disclosing Company information in confidence to a federal, state, or local government official for the purpose of reporting or investigating a suspected violation of law.
3.Non-Recruitment of Cardinal Group Employees, etc. Executive shall not, at any time during the Restricted Period (as defined below), without the prior written consent of the Company, engage in the following conduct (a "Solicitation"): (i) directly or indirectly, including via social media or professional networking services, solicit, recruit or employ (whether as an employee, officer, director, agent, consultant or independent contractor) any person who is or was at any time during the previous twelve months an employee, representative, officer or director of the Cardinal Group; or (ii) take any action to encourage or induce any employee, representative, officer or director of the Cardinal Group to cease his or her relationship with the Cardinal Group for any reason. A "Solicitation" does not include any recruitment of employees within or for the Cardinal Group. The "Restricted Period" means the period from the effective date of this Agreement until twenty-four months after Executive’s date of termination of employment or date of retirement, as applicable. The Restricted Period shall be extended and its expiration tolled by the time period in which Executive is in breach of any covenant in this Agreement to ensure that Executive does not benefit from any breach and that the Company receives the full benefit of two years protection from unfair competition on which it has relied in entering into this Agreement.
4.No Competition -- Solicitation of Business. During the Restricted Period, Executive shall not (either directly or indirectly or as an officer, agent, employee, partner, consultant or director of any other company, partnership or entity) solicit, service or accept on behalf of any competitor of the Cardinal Group the business of (i) any customer of the Cardinal Group during the time of Executive's employment or at date of termination of employment, or (ii) any potential customer of the Cardinal Group which Executive knew to be an identified, prospective purchaser of products or services of the Cardinal Group.
5.No Competition -- Employment by Competitor. During the Restricted Period, Executive shall not invest in (other than in a publicly traded company with a maximum investment of no more than 1% of outstanding shares), counsel, advise or be otherwise engaged or employed by any entity or enterprise that is in competition with the business conducted by any member of the Cardinal Group (other than a business that is not a significant business to the Cardinal Group as a whole or to the entity or enterprise as a whole).
6.No Disparagement. Executive shall at all times refrain from taking actions or making statements, written or oral, that (i) denigrate, disparage or defame the goodwill or reputation of the Cardinal Group, as the case may be, or any of its trustees, officers, security holders, partners, agents or former or current employees and directors, or (ii) are intended to, or may be reasonably expected to, adversely affect the morale of the employees of the Cardinal Group. Executive further agrees not to make any negative statements to third parties relating to Executive's employment or any aspect of the businesses of the Cardinal Group and not to make any statements to third parties about the circumstances of the termination of Executive's employment or about the Cardinal Group or its trustees, directors, officers, security holders, partners, agents or former or current employees and directors, except as may be required by a court or governmental body.
7.Cooperation. Executive agrees that, following termination of employment for any reason, Executive shall assist and cooperate with the Company with regard to any matter or project in which Executive was involved during Executive's employment with the Company, including but not limited to any litigation that may be pending or may
2


arise after such termination of employment. Further, Executive agrees to notify the Company at the earliest opportunity of any contact that is made by any third parties concerning any such matter or project unless prohibited by law. The Company shall not unreasonably request such cooperation of Executive and shall cooperate with Executive in scheduling any assistance by Executive, considering Executive’s business and personal affairs, and shall compensate Executive for any lost wages or expenses associated with such cooperation and assistance.
8.Work Product and Inventions. All of the following that the Executive creates, makes, compiles, prepares, or contributes to, solely or in collaboration with others, during the course of Executive's employment are the sole property of the Company: all works of authorship, plans, records, drawings, data, designs, inventions, discoveries, improvements, and trade secrets; all derivatives and modifications thereof and thereto; and all copyrights, patents and other intellectual property rights therein whether registrable or unregistered, patentable or unpatentable, made or devised by Executive, from the date of Executive's initial employment by the Company and continuing until the end of any period during which Executive is employed by the Cardinal Group, relating or pertaining in any way to Executive's employment with or the business of the Cardinal Group (collectively, “Work Product”). The Executive shall promptly disclose all Work Product to the Company. The Executive agrees that all of the Work Product in fixed form constitutes “collective works,” “supplementary works,” “compilations,” and/or “instructional texts” as those terms are used under the Copyright Act of 1976, and all such Work Product that the Service Provider creates, makes, compiles, prepares, or contributes to, solely or in collaboration with others, shall be considered “works made for hire” under the laws of the United States and that the Company shall be considered the author of such works made for hire. Executive further agrees to assign and transfer (or cause to be assigned and transferred), and does hereby assign and transfer, fully and permanently to the Company, all of Executive's other rights, titles and interests in and to any and all Work Product without need for a separate writing or additional consideration and to execute any other instruments and documents requisite or desirable to the Company in applying for and obtaining patents, trademarks or copyrights or otherwise reasonably related to a business purpose, at the expense of the Company, with respect thereto in the United States and in all foreign countries. Executive further agrees at all times to cooperate to the extent and in the manner required by the Company in the prosecution or defense of any patent, trademark, copyright, trade secret, or unfair competition claims or any litigation or other proceeding involving any Work Product covered by this Agreement, but all necessary expenses thereof shall be paid by the Company. For the avoidance of doubt, “Work Product” does not include subject matter created by Executive on Executive’s own time without the use of Company equipment, property, or resources, and that does not relate to Executive’s work for the Company and is not otherwise based on Executive’s duties for or to the Company or knowledge of the Company.
9.Acknowledgement and Enforcement. Executive acknowledges and agrees that: (a) the purpose of the foregoing covenants, including without limitation the noncompetition covenants of Sections 4 and 5, is to protect the goodwill, trade secrets and other Confidential Information of the Company; (b) because of the nature of the business in which the Cardinal Group is engaged and because of the nature of the Confidential Information to which Executive has access, the Company would suffer irreparable harm and it would be impractical and excessively difficult to determine the actual damages of the Cardinal Group in the event Executive breached any of the covenants of this Agreement; and (c) remedies at law (such as monetary damages) for any breach of Executive's obligations under this Agreement would be inadequate. Executive therefore agrees and consents that if Executive commits any breach of a covenant under this Agreement or threatens to commit any such breach, the Company shall have the right (in addition to, and not in lieu of, any other right or remedy that may be available to it) to temporary and permanent injunctive relief from a court of competent jurisdiction, without posting any bond or other security and without the necessity of proof of actual damage. If any of the covenants contained in this Agreement are finally held by a court to be invalid, illegal or
3


unenforceable (whether in whole or in part), such covenant shall be deemed modified to the extent, but only to the extent, of such invalidity, illegality or unenforceability and the remaining covenants shall not be affected thereby; provided, however, that if any of such covenants is finally held by a court to be invalid, illegal or unenforceable because it exceeds the maximum scope or duration determined to be acceptable to permit such provision to be enforceable, such covenant will be deemed to be modified to the minimum extent necessary to modify such scope or duration in order to make such provision enforceable hereunder.
10.Miscellaneous.
(a)This Agreement shall be governed by and construed in accordance with the laws of the State of Ohio, without reference to principles of conflict of laws. If, under any such law, any portion of this Agreement is at any time deemed to be in conflict with any applicable statute, rule, regulation or ordinance, such portion shall be deemed to be modified or altered to conform thereto. The parties hereto irrevocably agree to submit to the jurisdiction and venue of the federal and state courts in the State of Ohio in any action or proceeding brought with respect to or in connection with this Agreement. The captions of this Agreement are not part of the provisions hereof and shall have no force or effect. This Agreement constitutes the entire agreement of the parties with respect to the subject matter hereof. This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives. This Agreement is the product of negotiation and shall not be construed strictly for or against any party.
(b)All notices and other communications under this Agreement shall be in writing and shall be given by hand delivery to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows:
If to Executive:    At the most recent address on file for Executive at the Company

If to the Company:    Cardinal Health, Inc.
    7000 Cardinal Place
    Dublin, Ohio 43017
    Attention: Corporate Secretary

or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when received by the addressee.

(c)The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement. If any provision of this Agreement shall be held invalid or unenforceable in part, the remaining portion of such provision, together with all other provisions of this Agreement, shall remain valid and enforceable and continue in full force and effect to the fullest extent consistent with the law.
(d)Executive's or the Company's failure to insist upon strict compliance with any provision of this Agreement or the failure to assert any right Executive or the Company may have hereunder, shall not be deemed to be a waiver of such provision or right or any other provision or right of this Agreement.
IN WITNESS WHEREOF, Executive has hereunto set Executive's hand and the Company has caused these presents to be executed in its name and on its behalf, all as of the day and year first above written.


4


EXECUTIVE


/s/ Aaron E. Alt                
Execution Date: 12.12.22            

CARDINAL HEALTH, INC.


/s/ Ola M. Snow                
By: Ola M. Snow
Its: Chief Human Resources Officer
Execution Date: 12-12-2022            

5
EX-99.1 4 cfopressrelease.htm EX-99.1 Document
Exhibit 99.1
Cardinal Health Names Aaron Alt Chief Financial Officer

DUBLIN, OHIO – December 19, 2022 — Cardinal Health (NYSE: CAH) and its board of directors announced today that Aaron Alt will become the company’s new chief financial officer (CFO). Alt will succeed interim CFO, Trish English and will report to CEO, Jason Hollar, as a member of the company's Executive Committee effective Feb. 10.
In his capacity as CFO, Alt will lead financial activities across the enterprise, including Financial Strategy, Capital Deployment, Treasury, Tax, Investor Relations, Accounting, and Reporting. Additionally, he will lead the Corporate Development team.
“We’re pleased to welcome Aaron as the new CFO of Cardinal Health,” said Jason Hollar, CEO of Cardinal Health. “He’s an exceptional talent with a breadth of experience across complex organizations that will position him well for this critical companywide role. I’d also like to thank Trish for her contributions as interim CFO and her commitment to help with this transition.”
Alt most recently served as EVP and CFO for Sysco Corporation, the leading global foodservice distribution company. In this role, he drove significant improvements to the balance sheet and underlying profitability of Sysco.
Prior to Sysco, Alt was SVP and CFO for Sally Beauty Holdings, an international specialty retailer and wholesale distributor of professional beauty supplies. He has also held senior executive roles in Finance, Operations and Grocery Transformation at Target Corporation. Prior to joining Target, he held senior-level Finance and Operations positions with Sara Lee Corporation.
Aaron holds an M.B.A. from the J.L. Kellogg School of Management at Northwestern University, a J.D. from Harvard Law School and a B.A. in History and Political Science from Northwestern University.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With more than 50 years in business, operations in more than 30 countries and approximately 46,500 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Contacts
Media: Erich Timmerman, erich.timmerman@cardinalhealth.com and (614) 757-8231
Investors: Kevin Moran, kevin.moran@cardinalhealth.com and (614) 757-7942

# # #


EX-101.SCH 5 cah-20221216.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 cah-20221216_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 7 cah-20221216_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 image_0.jpg begin 644 image_0.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover Page
Dec. 16, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Dec. 16, 2022
Entity Registrant Name Cardinal Health, Inc.
Entity Incorporation, State or Country Code OH
Entity File Number 1-11373
Entity Tax Identification Number 31-0958666
Entity Address, Address Line One 7000 Cardinal Place
Entity Address, City or Town Dublin
Entity Address, State or Province OH
Entity Address, Postal Zip Code 43017
City Area Code 614
Local Phone Number 757-5000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common shares (without par value)
Trading Symbol CAH
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0000721371
Amendment Flag false
XML 10 cah-20221216_htm.xml IDEA: XBRL DOCUMENT 0000721371 2022-12-16 2022-12-16 0000721371 false 8-K 2022-12-16 Cardinal Health, Inc. OH 1-11373 31-0958666 7000 Cardinal Place Dublin OH 43017 614 757-5000 false false false false Common shares (without par value) CAH NYSE false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.cardinal.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports cah-20221216.htm altcbpagreement.htm altofferletter.htm cah-20221216.xsd cah-20221216_lab.xml cah-20221216_pre.xml cfopressrelease.htm http://xbrl.sec.gov/dei/2021 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cah-20221216.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "cah-20221216.htm" ] }, "labelLink": { "local": [ "cah-20221216_lab.xml" ] }, "presentationLink": { "local": [ "cah-20221216_pre.xml" ] }, "schema": { "local": [ "cah-20221216.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "cah", "nsuri": "http://www.cardinal.com/20221216", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cah-20221216.htm", "contextRef": "iea17e1519bca474db60800b302a58f5e_D20221216-20221216", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.cardinal.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cah-20221216.htm", "contextRef": "iea17e1519bca474db60800b302a58f5e_D20221216-20221216", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 17 0000721371-22-000181-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000721371-22-000181-xbrl.zip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